Analysis of protective immune responses to the glycoprotein H-glycoprotein L complex of herpes simplex virus type 1

References

1. Berman P. W., Gregory T., Crase D., Laskey L. A. 1985; Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 227:1490–1492
   [Google Scholar]
2. Blacklaws B., Krishna S., Minson A. C., Nash A. A. 1990; Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177:727–736
   [Google Scholar]
3. Cantin E. M., Eberle R., Baldick J. L., Moss B., Willey D. E., Notkins A. L., Openshaw H. 1987; Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proceedings of the National Academy of Sciences, U.S.A 84:5908–5912
   [Google Scholar]
4. Chakrabarti S., Brechling K., Moss B. 1985; Vaccinia expression vector: co-expression of β-galactosidase gene provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5:3403–3409
   [Google Scholar]
5. Chan W. L., Lukig M. L., Liew F. Y. 1985; Helper T cells induced by an immunopurified herpes simplex virus type 1 (HSV-1) 115 kilodalton glycoprotein B (gB) protects mice against HSV-1 infection. Journal of Experimental Medicine 162:1304–1318
   [Google Scholar]
6. Cranage M. P., Smith G. L., Bell S. E., Hart H., Brown C., Bankier A. T., Tomlinson P., Barrell B. G., Minson A. C. 1988; Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII and herpes simplex virus type 1 glycoprotein H. Journal of Virology 62:1416–1422
   [Google Scholar]
7. Cremer K. J., Mackett M., Wohlenberg C., Notkins A. L., Moss B. 1985; Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228:737–740
   [Google Scholar]
8. Davison A. J., Taylor P. 1987; Genetic relations between varicella-zoster virus and Epstein-Barr virus. Journal of General Virology 68:1067–1079
   [Google Scholar]
9. Desai P. J., Schaffer P. A., Minson A. C. 1988; Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex type 1: evidence that gH is essential for virion infectivity. Journal of General Virology 69:1147–1156
   [Google Scholar]
10. Eisenberg R. J., Cerini C. P., Heilman C. J., Joseph A. D., Dietzschold B., Golub E., Long D., Ponce de Leon M., Cohen G. H. 1985; Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. Journal of Virology 56:1014–1017
    [Google Scholar]
11. Foa-Tomasi L., Avitabile E., Boscaro A., Brandimarti R., Gualandri R., Manservigi R., Dall’Olio F., Serafini-Cessi F., Campadelli-Fiume G. 1991; Herpes simplex virus (HSV) glycoprotein H is partially processed in a cell line that expressed the glycoprotein and fully processed in cells infected with deletion or ts mutants in the known HSV glycoproteins. Virology 180:474–482
    [Google Scholar]
12. Forrester A. J., Sullivan V., Simmons A., Blacklaws B. A., Smith G. L., Nash A. A., Minson A. C. 1991; Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. Journal of General Virology 72:369–375
    [Google Scholar]
13. Forrester A., Farrell H., Wilkinson G., Kaye J., DavisPoynter N., Minson T. 1992; Construction and properties of a mutant of herpes simplex type 1 with glycoprotein H coding sequences deleted. Journal of Virology 66:341–348
    [Google Scholar]
14. Fuller A. O., Santos R. E., Spear P. G. 1989; Neutralising antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. Journal of Virology 63:3435–3443
    [Google Scholar]
15. Ghiasi H., Kaiwar R., Nesburn A. B., Wechsler S. L. 1992; Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge. Journal of General Virology 73:719–722
    [Google Scholar]
16. Glorioso J., Kees V., Kumel G., Kirschner H., Krammer P. 1985; Identification of herpes simplex virus type 1 (HSV-1) glycoprotein C as the immunodominant antigen for HSV-1 specific memory cytotoxic T lymphocytes. Journal of Immunology 135:575–582
    [Google Scholar]
17. Gompels U., Minson A. 1986; The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology 153:230–247
    [Google Scholar]
18. Gompels U. A., Minson A. C. 1989; Antigenic properties and cellular localisation of herpes simplex virus glycoprotein H synthesised in a mammalian cell expression system. Journal of Virology 63:4744–4755
    [Google Scholar]
19. Gompels U. A., Craxton M. A., Honess R. W. 1988; Conservation of glycoprotein H (gH) in herpesviruses: nucleotide sequence of the gH gene from herepesvirus saimiri. Journal of General Virology 69:2819–2829
    [Google Scholar]
20. Heineman T., Gong M., Sample J., Kieff E. 1988; Identification of the Epstein-Barr virus gp85 gene. Journal of Virology 62:1101–1107
    [Google Scholar]
21. Hutchinson L., Browne H., Wargent V., Davis-Poynter N., Primorac S., Goldsmith K., Minson A. C., Johnson D. C. 1992; A novel herpes simplex virus glycoprotein gL forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. Journal of Virology 66:2240–2250
    [Google Scholar]
22. Kaye J. F., Gompels U. A., Minson A. C. 1992; Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. Journal of General Virology 73:2693–2698
    [Google Scholar]
23. Keller P. M., Davison A. J., Lowe R. S., Riemen M. W., Ellis R. W. 1987; Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus. Virology 157:526–533
    [Google Scholar]
24. Klupp B., Mettenleiter T. C. 1991; Sequence and expression of the glycoprotein H gene of pseudorabies virus. Virology 182:732–741
    [Google Scholar]
25. Krishna S., Blacklaws B. A., Overton H. A., Bishop D. H. L., Nash A. A. 1989; Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts. Journal of General Virology 70:1805–1814
    [Google Scholar]
26. Kunkel T. A., Roberts J. D., Zakour R. A. 1987; Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods in Enzymology 154:367–382
    [Google Scholar]
27. Mackett M., Smith G. L., Moss B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
    [Google Scholar]
28. McLaughlin-Taylor E., Willey D. E., Cantin E. M., Eberle R., Moss B., Openshaw H. 1988; A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice. Journal of General Virology 69:1731–1734
    [Google Scholar]
29. Martin S., Cantin E., Rouse B. T. 1989; Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins. Journal of General Virology 70:1359–1370
    [Google Scholar]
30. Miller N., Hutt-Fletcher L. M. 1988; A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein Barr virus. Journal of Virology 62:2366–2372
    [Google Scholar]
31. Nash A. A., Leung K.-N., Wildy P. 1985; The T-cell mediated immune response of mice to herpes simplex virus. In The Herpesviruses vol 4 pp 87–103 Edited by Roizman B., Lopez C. New York: Plenum Press;
    [Google Scholar]
32. Showalter S. D., Zweig M., Hampar B. 1981; Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate early protein ICP4. Infection and Immunity 534:684–692
    [Google Scholar]
33. Simmons A., Nash A. A. 1985; Role of antibody in primary and recurrent herpes simplex virus infection. Journal of Virology 53:944–948
    [Google Scholar]
34. Weir J. P., Bennett M., Allen E. M., Elkins K. L., Martin S., Rouse B. T. 1989; Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. Journal of General Virology 70:2587–2594
    [Google Scholar]